ATE285231T1 - Verwendung von aryl-n-substituierten carboxamiden zum töten von tumoren - Google Patents

Verwendung von aryl-n-substituierten carboxamiden zum töten von tumoren

Info

Publication number
ATE285231T1
ATE285231T1 AT97915884T AT97915884T ATE285231T1 AT E285231 T1 ATE285231 T1 AT E285231T1 AT 97915884 T AT97915884 T AT 97915884T AT 97915884 T AT97915884 T AT 97915884T AT E285231 T1 ATE285231 T1 AT E285231T1
Authority
AT
Austria
Prior art keywords
aryl
substituted carboxamides
kill tumors
substituted
kill
Prior art date
Application number
AT97915884T
Other languages
English (en)
Inventor
Ronald W Pero
Anders Olsson
Tomas Ekberg
Alan Schwartz
David Chaplin
Original Assignee
Oxigene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxigene Inc filed Critical Oxigene Inc
Application granted granted Critical
Publication of ATE285231T1 publication Critical patent/ATE285231T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97915884T 1996-03-08 1997-03-03 Verwendung von aryl-n-substituierten carboxamiden zum töten von tumoren ATE285231T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1307296P 1996-03-08 1996-03-08
PCT/US1997/003659 WO1997032576A1 (en) 1996-03-08 1997-03-03 Use of aryl n-substituted carboxamides to kill tumors

Publications (1)

Publication Number Publication Date
ATE285231T1 true ATE285231T1 (de) 2005-01-15

Family

ID=21758161

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97908038T ATE300300T1 (de) 1996-03-08 1997-03-03 Zusammensetzungen und verwendungvon benzamiden als entzuendungshemmende mittel
AT97915884T ATE285231T1 (de) 1996-03-08 1997-03-03 Verwendung von aryl-n-substituierten carboxamiden zum töten von tumoren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT97908038T ATE300300T1 (de) 1996-03-08 1997-03-03 Zusammensetzungen und verwendungvon benzamiden als entzuendungshemmende mittel

Country Status (10)

Country Link
US (1) US6028111A (de)
EP (2) EP0927030B1 (de)
JP (2) JP2000506169A (de)
AT (2) ATE300300T1 (de)
AU (2) AU724909B2 (de)
CA (2) CA2248109A1 (de)
DE (2) DE69733843T2 (de)
IL (2) IL126110A0 (de)
WO (2) WO1997032576A1 (de)
ZA (2) ZA971892B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW429148B (en) * 1995-10-27 2001-04-11 Pfizer Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
US6100299A (en) * 1996-03-08 2000-08-08 Oxigene, Inc. N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use
PL190755B1 (pl) * 1999-01-07 2006-01-31 Pharmena Sp Z Oo Preparat do leczenia i profilaktyki chorób skóry
EE05006B1 (et) 1999-01-11 2008-04-15 Agouron Pharmaceuticals, Inc. Polü(ADP-riboos)polümeraaside tritsüklilised inhibiitorid ja neid sisaldavad farmatseutilised kompositsioonid
IT1306141B1 (it) * 1999-05-17 2001-05-30 Giampiero Valletta Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.
AU2001231143A1 (en) * 2000-01-27 2001-08-07 Cytovia, Inc. Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
BR0209965A (pt) 2001-05-21 2004-04-06 Alcon Inc Uso de inibidores de nf-kappab para tratar distúrbios do olho seco
US20040067985A1 (en) * 2002-10-04 2004-04-08 Fortuna Haviv Method of inhibiting angiogenesis
US7332479B2 (en) * 2003-09-10 2008-02-19 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Extracellular NAD+ and cADPR as potent anti-inflammatory agents
DE102004011720B4 (de) * 2004-03-10 2008-04-03 Bayer Schering Pharma Aktiengesellschaft Radiohalogenierte Benzamidderivate und deren Verwendung in der Tumordiagnostik und Tumortherapie
WO2005090302A2 (en) * 2004-03-16 2005-09-29 Boehringer Ingelheim International Gmbh Palladium catalyzed indolization of 2-bromo or chloroanilines
MX2007011200A (es) * 2005-03-16 2008-04-02 Ronald W Pero Composiciones medicinales de sales, quelatos y/o acidos libres de acidos organicos de alfa-hidroxilo y procesos y metodos relacionados.
US20070014833A1 (en) * 2005-03-30 2007-01-18 Sirtris Pharmaceuticals, Inc. Treatment of eye disorders with sirtuin modulators
EP1877054A2 (de) * 2005-03-30 2008-01-16 Sirtris Pharmaceuticals, Inc. Nicotinamidribosid und analoge davon
US20060292099A1 (en) * 2005-05-25 2006-12-28 Michael Milburn Treatment of eye disorders with sirtuin modulators
US20070149466A1 (en) * 2005-07-07 2007-06-28 Michael Milburn Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
US11896564B2 (en) 2018-08-15 2024-02-13 Pharmacyl Ab Medical treatment for pathologic inflammation
WO2023097322A2 (en) * 2021-11-29 2023-06-01 The Procter & Gamble Company Skin care composition

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3055891A (en) * 1960-03-21 1962-09-25 Searle & Co N-(aminoalkylcarbamoylpiperidinoalkyl)phenothiazines
CH481132A (de) * 1966-06-09 1969-11-15 Ciba Geigy Verfahren zur Herstellung von neuen Isoxazolen
FR8287M (de) * 1968-12-31 1970-11-09
DE2623228C3 (de) * 1976-05-24 1981-09-10 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren N-Acyl-substituierte Benzamide, Verfahren zu ihrer Herstellung und Arzneimittel, enthaltend solche Benzamide
GB1573186A (en) * 1977-09-14 1980-08-20 Wyeth John & Brother Ltd 4-aminoquinoline derivatives
US4394389A (en) * 1979-03-01 1983-07-19 Riet Bartholomeus Van T Hydroxybenzohydroxamic acids, benzamides and esters as ribonucleotide reductase inhibitors
US4263322A (en) * 1979-03-01 1981-04-21 Riet Bartholomeus Van T Hydroxy benzohydroxamic acids and benzamides
US4448730A (en) * 1981-03-24 1984-05-15 Riet Bartholomeus Van T Hydroxybenzohydroxamic acids, benzamides and esters and related compounds as ribonucleotide reductase inhibitors
WO1984004246A1 (en) * 1983-04-21 1984-11-08 Howard L Elford Oncolytic drug combinations
US4623659A (en) * 1983-05-23 1986-11-18 Riet Bartholomeus Van T Polyhydroxybenzoic acid derivatives
US4942253A (en) * 1983-05-23 1990-07-17 Riet Bartholomeus Van T Polyhydroxybenzoic acid derivatives
US5183828A (en) * 1983-05-23 1993-02-02 Riet Bartholomeus Van T Polyhydroxybenzoic acid derivatives
US5215738A (en) * 1985-05-03 1993-06-01 Sri International Benzamide and nicotinamide radiosensitizers
ZA885929B (en) * 1987-08-25 1989-04-26 Oxi Gene Inc Agents for use in tumor or cancer cell killing therapy
US5281623A (en) * 1990-08-27 1994-01-25 Eli Lilly And Company Method for treating inflammation
WO1993012782A1 (en) * 1991-10-31 1993-07-08 Elford Howard L Method of treating viral diseases
US5350770A (en) * 1992-07-28 1994-09-27 Elford Howard L Therapeutic process for the treatment of septic shock
US5366996A (en) * 1992-12-07 1994-11-22 Elford Howard L Method of treating hemoglobinopathies
FR2712809B1 (fr) * 1993-11-26 1996-04-12 Union Pharma Scient Appl Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide.
US5563143A (en) * 1994-09-21 1996-10-08 Pfizer Inc. Catechol diether compounds as inhibitors of TNF release
CA2502764A1 (en) * 1995-08-22 1997-03-06 Japan Tobacco Inc. Amide compounds
TW429148B (en) * 1995-10-27 2001-04-11 Pfizer Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases

Also Published As

Publication number Publication date
EP1009402B1 (de) 2005-07-27
AU724909B2 (en) 2000-10-05
JP2000506169A (ja) 2000-05-23
WO1997032582A1 (en) 1997-09-12
US6028111A (en) 2000-02-22
IL126110A0 (en) 1999-05-09
ZA971891B (en) 1998-09-07
DE69733843D1 (de) 2005-09-01
EP0927030A4 (de) 2000-01-26
AU2319697A (en) 1997-09-22
WO1997032576A1 (en) 1997-09-12
EP0927030B1 (de) 2004-12-22
EP0927030A1 (de) 1999-07-07
DE69732036D1 (de) 2005-01-27
IL126109A0 (en) 1999-05-09
JP2000507223A (ja) 2000-06-13
ZA971892B (en) 1998-09-07
DE69733843T2 (de) 2006-06-01
CA2248125A1 (en) 1997-09-12
EP1009402A1 (de) 2000-06-21
CA2248109A1 (en) 1997-09-12
AU723706B2 (en) 2000-09-07
ATE300300T1 (de) 2005-08-15
EP1009402A4 (de) 2000-06-21
AU1988497A (en) 1997-09-22

Similar Documents

Publication Publication Date Title
DE69732036D1 (de) Verwendung von aryl-n-substituierten carboxamiden zum töten von tumoren
DE69805202D1 (de) Verwendung von benzhydrylsulfinylderivaten zur behandlung der schläfigkeit medikamentösen ursprungs
DE69725293D1 (de) N-(2 oxoacetyl oder sulphonyl)-pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität
IT1177389B (it) Composizioni analgesiche ed anti-infiammatorie migliorate, comprendente xantine e metodi di utilizzare le stesse
FI956333A7 (fi) Fluorialkoksilla substituoidut bentsamidit ja niiden käyttö syklisen nukleotidin fosfodiesteraasiestäjinä
DE50015700D1 (de) Substituierte indole zur modulierung von nfkb-aktivität
ATE126215T1 (de) Anti-entzündende 4-aminophenol-derivate.
EA199900279A1 (ru) Производные бензамида и их применение в качестве лекарственных средств с лтв4-антагонистической активностью
UY25712A1 (es) Benzamidas sustituidas y su aplicación en medicamentos
NO982570D0 (no) Benzofurankarboksamider og -sulfonamider
SE9701161D0 (sv) New use I
BG103558A (en) Sulphonic acid or sulphonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
DE59906365D1 (de) Benzamide mit tetrahydrofuranyloxy-substituenten als inhibitoren der phosphodiesterase 4
ATE229034T1 (de) 3-mercaptoacetylamino-1,5-substituierte-2-oxo- azepan derivate und deren verwendung als inhibitoren von matrix-metalloproteinasen
DE69414194D1 (de) Aminosäurederivate und ihre Verwendung als Enkephalinase-Inhibitoren
MX9202366A (es) Nuevas 2-amino-5-ciano-1,4-di hidro piridinas y procedimiento para su fabricacion.
ES2120506T3 (es) Nuevas amidas, sulfonamidas y sulfonamidas de piperidilo utilizadas como inhibidores de la biosintesis del colesterol.
DK170987A (da) N-substituerede benzamider, deres fremstilling og anvendelse
MY8200038A (en) N-(1,3,4-thiadiazol-2yl)benzamides and their use as insecticides
ATE66591T1 (de) Pantethinkomponente zum dauerwellen von haar.
FI961339A0 (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
JO1120B1 (en) N-(1-allye-2-pyrrolidiny-methyl)2methoxy-4-amino-5-methylsulfamoyl benzamide, its method of oreperation and its use as a medicament
ATE30024T1 (de) Carbamate und oxalylamide von amino-n-(1htetrazol-5-yl)benzamiden.
BG45853A3 (bg) Метод за получаване на бензамидни съединения
ATE239076T1 (de) Zielspezifische abgabe zum nukleus mittels protein h von streptococcus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties